Finance Minister Nirmala Sitharaman said the government would provide 75 per cent coverage for new projects and 50 per cent for those in expansion mode in the non-metros. A maximum loan of up to Rs 100 crore would be given for up to three years at the interest rate capped at 7.95 per cent.
“The scheme could greatly benefit smaller entities that form the majority of the private health care sector to access funding to create enhanced capacities and capabilities,” said Dilip Jose, managing and chief executive of Manipal hospitals. Gurpreet Sandhu, President, Council for Healthcare & Pharma, called the package a sign of the government’s commitment towards improving the battered state of affairs in the health care sector.
“India’s Covid-19 catastrophe was a result of years of neglecting its public health care structure and a substantial investment to ameliorate the infrastructure is of utmost importance now.”
While the smaller players are likely to benefit from the loan guarantee scheme, some in the medical industry said no private hospital is keen on tier II and III cities as there is no availability of doctors. “The government has to think of ways to create a pool of qualified doctors. Unless there is the availability of medical personnel, no hospital would work,” said Girdhar Gyani, director general, Association of Healthcare Providers.
The announcement has also triggered criticism with the industry players saying the medical procedure rates under the Ayushman Bharat scheme are not viable. “The Centre does not know what the actual cost to deliver a particular medical procedure is. The rates are fixed ad hoc,” Gyani said.
“With the predictions of an even more destructive third wave, these policy stimuli would give some momentum to health facilities and infrastructure in the immediate term too,” said Ashok Patel, CEO & Founder, Max Ventilator.
The additional allocation would finance equipment, medicines, access to teleconsultation, ambulance services, ramping up human resource capabilities. Besides child care, these funds would be used for ramping up testing capacity and supportive diagnostics and to strengthen capacity for surveillance and genome sequencing.
needs to be done to make up for the neglect of the sector over the past several decades. “There can be no better time than the present, to fulfil the long-pending demand of the sector to be accorded infrastructure status, in both letter and spirit, to enable the nation to frog leap to the next level of health care,” said Harsh Mahajan, president, NATHEALTH. Mahajan said the loans should be provided readily to the private sector for upgrading infrastructure and building new ones, at very low-interest rates, preferably zero. “... As the return on investment in this sector is very slow and low.”
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)